Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population‐based cohort study

To estimate the risk of gastrointestinal (GI) bleeding associated with serotonin reuptake inhibitors (SSRIs) by level of kidney function.

[1]  L. Smeeth,et al.  Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink , 2017, Pharmacoepidemiology and drug safety.

[2]  L. Tomlinson,et al.  Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  L. Tomlinson,et al.  Methodological challenges when carrying out research on CKD and AKI using routine electronic health records. , 2016, Kidney international.

[4]  Lord Bourne,et al.  Department for Communities and Local Government: Troubled families programme: transforming the lives of thousands of families , 2016 .

[5]  J. Coresh,et al.  Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[6]  A. Garg,et al.  The Risk of Major Hemorrhage with CKD. , 2016, Journal of the American Society of Nephrology : JASN.

[7]  Maarten W. Taal,et al.  The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study , 2015, BMC Nephrology.

[8]  K. Bhaskaran,et al.  Data Resource Profile: Clinical Practice Research Datalink (CPRD) , 2015, International journal of epidemiology.

[9]  M. Tonelli,et al.  The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study , 2015, BMJ : British Medical Journal.

[10]  D. Singer,et al.  Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. , 2014, The American journal of cardiology.

[11]  Carol Coupland,et al.  Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores , 2014, BMJ : British Medical Journal.

[12]  J. Liu,et al.  Peptic Ulcer Disease Risk in Chronic Kidney Disease: Ten-Year Incidence, Ulcer Location, and Ulcerogenic Effect of Medications , 2014, PloS one.

[13]  Arthur V. Iansavichus,et al.  The Risk of Perioperative Bleeding in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis , 2013, Annals of surgery.

[14]  David W. Johnson,et al.  Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. , 2013, Kidney international.

[15]  M. Kim,et al.  Association of depression and anxiety with reduced quality of life in patients with predialysis chronic kidney disease , 2013, International journal of clinical practice.

[16]  J. West,et al.  Defining upper gastrointestinal bleeding from linked primary and secondary care data and the effect on occurrence and 28 day mortality , 2012, BMC Health Services Research.

[17]  Corri Black,et al.  Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  J. Moncrieff,et al.  Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. , 2012, The British journal of psychiatry : the journal of mental science.

[19]  S. Hedayati,et al.  A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. , 2012, Kidney international.

[20]  J. Hippisley-Cox,et al.  Antidepressant use and risk of adverse outcomes in older people: population based cohort study , 2011, BMJ : British Medical Journal.

[21]  J. Hippisley-Cox,et al.  A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. , 2011, Health technology assessment.

[22]  Chun-Ju Hsiao,et al.  National Ambulatory Medical Care Survey: 2000 summary. , 2002, Advance data.

[23]  Hendriek C Boshuizen,et al.  Fitting additive Poisson models , 2010, Epidemiologic perspectives & innovations : EP+I.

[24]  J. Hallas,et al.  Association Between Selective Serotonin Reuptake Inhibitor Use and erious Upper Gastrointestinal Bleeding , 2022 .

[25]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[26]  R. McIntyre,et al.  Psychotropic drugs and renal failure: Translating the evidence for clinical practice , 2009, Advances in therapy.

[27]  F. D. de Abajo,et al.  Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. , 2008, Archives of general psychiatry.

[28]  S. Suissa,et al.  Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. , 2008, British journal of clinical pharmacology.

[29]  A. Localio,et al.  Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity , 2008, Pharmacoepidemiology and drug safety.

[30]  V. Serebruany.  Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? , 2006, The American journal of medicine.

[31]  A. Egberts,et al.  Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. , 2004, Archives of internal medicine.

[32]  W. Ray,et al.  Evaluating medication effects outside of clinical trials: new-user designs. , 2003, American journal of epidemiology.

[33]  J. Olsen,et al.  Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. , 2003, Archives of internal medicine.

[34]  C. van Walraven,et al.  Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study , 2001, BMJ : British Medical Journal.

[35]  F. D. de Abajo,et al.  Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study , 1999, BMJ.

[36]  D. Goldfarb.  Brenner and Rector's The Kidney, 5th ed , 1996 .

[37]  S Greenland,et al.  Additive Risk versus Additive Relative Risk Models , 1993, Epidemiology.

[38]  S Greenland,et al.  Concepts of interaction. , 1980, American journal of epidemiology.

[39]  M. Pedrosa,et al.  Evidence‐based Review of Gastrointestinal Bleeding in the Chronic Kidney Disease Patient , 2015, Seminars in dialysis.

[40]  B. Ruan,et al.  Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[42]  F. Chang,et al.  Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. , 2014, The American journal of psychiatry.

[43]  A. Rush,et al.  Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). , 2013, Contemporary clinical trials.

[44]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[45]  Northgate.  Hospital Episode Statistics , 2006 .

[46]  W. G. Walker,et al.  Plasma aldosterone regulation in anephric man. , 1973, Kidney international.

[47]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.